
Opinion|Videos|May 13, 2024
Amyloid Cascade Hypothesis of Alzheimer’s Disease
Panelists delve into the amyloid cascade hypothesis of Alzheimer's disease and the ongoing debate surrounding it, discussing the presence and potential roles of Aβ monomers, oligomers, protofibrils, and amyloid plaques in patients with Alzheimer's disease.
Advertisement
Episodes in this series

- What is the amyloid cascade hypothesis of Alzheimer’s disease?
- When are Aβ monomers, oligomers, protofibrils and amyloid plaques seen in patients with Alzheimer’s disease?
- What are the strengths and weaknesses of amyloid cascade hypothesis?
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
REGENXBIO's MPS II Gene Therapy RGX-121 Hit With CRL
2
Cladribine Tablets Reduce Treatment Switches, Outpatient Visits, and Health Care Costs in Multiple Sclerosis
3
AGNOS Study Results Demonstrate Ofatumumab’s Impact on Neurofilament Light, GFAP
4
Rethinking Multiple Sclerosis Clinical Course Classifications in the Modern Era: Daniel Ontaneda, MD, PhD
5











